Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;46(6):6071-6078.
doi: 10.1007/s11033-019-05042-9. Epub 2019 Aug 27.

Molecular pathways related to the control of proliferation and cell death in 786-O cells treated with plumbagin

Affiliations

Molecular pathways related to the control of proliferation and cell death in 786-O cells treated with plumbagin

Igor Alves Mancilla et al. Mol Biol Rep. 2019 Dec.

Abstract

Plumbagin (PLB) is a phytochemical being used for centuries in traditional medicines. Recently, its capacity to inhibit the development of human tumors has been observed, through the induction of apoptosis, cell cycle arrest, and inhibition of angiogenesis and metastasis. Here we evaluated the mechanism of action of PLB in the kidney adenocarcinoma 786-O cell line, which are metabolizing cells important for toxicology studies. After the treatment with PLB, we observed increased apoptosis and cell cycle arrest in S and G2/M phases, starting at 5 µM. In addition, PLB was cytotoxic, genotoxic and induced loss of cell membrane integrity. Regarding gene expression, treatment with 7.5 µM PLB reduced the amount of MTOR, BCL2 and ATM transcripts, and increased CDKN1A (p21) transcripts. Phosphorylation levels of yH2AX was increased and MDM2 protein level was reduced following the treatment with PLB, demonstrating its genotoxic effect. Our results suggest that PLB acts in molecular pathways related to the control of proliferation and cell death in 786-O cells.

Keywords: Antiproliferative; Apoptosis; Cell cycle; Cytotoxicity; DNA damage; Gene expression.

PubMed Disclaimer

References

    1. Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79(3):629–661. https://doi.org/10.1021/acs.jnatprod.5b01055 - DOI - PubMed
    1. Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R (2009) Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci 5(1):1–11 - PubMed - PMC
    1. Greenwell M, Rahman PK (2015) Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res 6(10):4103–4112. https://doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12 - DOI - PubMed - PMC
    1. Gillet JP, Varma S, Gottesman MM (2013) The clinical relevance of cancer cell lines. J Natl Cancer Inst 105(7):452–458. https://doi.org/10.1093/jnci/djt007 - DOI - PubMed - PMC
    1. Guengerich FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14(6):611–650 - DOI

MeSH terms

LinkOut - more resources